Publications by authors named "Raquel Feijo"
Article Synopsis
- - The study analyzed 64 patients with small cell lung cancer (SCLC) to assess the expression of Delta-like ligand 3 (DLL3) and other neuroendocrine markers using immunohistochemistry and digital pathology tools; DLL3 was found expressed in 72.3% of patients.
- - The majority of patients were older adults (median age over 71), and notable findings included high expression rates of ASCL1 (97%) and a potential new role for TTF-1 as a biomarker, as it was positive in half of the cases.
- - The research highlights the variability of neuroendocrine marker expression in SCLC, suggesting that DLL3 could be a therapeutic target, while the
